Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Glaxo obtains license to technology and porphyrin compound for dermatological diseases

May 12, 1997

Roche gains access to combinatorial libraries

May 9, 1997

Pall and LifeTECH will not pursue strategic alliance

May 8, 1997

GeneMedicine reports development of a negative GeneSwitch

May 8, 1997

UCSF and Stanford develop mouse model of basal cell carcinoma

May 8, 1997

CombiChem and Teijin extend collaborative agreement

May 7, 1997

Helix BioPharma enters research and development agreement

May 6, 1997

ArQule and Genzyme collaborate on the discovery and development of novel drug candidates

May 5, 1997

Alanex and ICOS enter small-molecule drug discovery collaboration

May 5, 1997

Nanogen granted U.S. patent on APEX technology

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...